271 related articles for article (PubMed ID: 36838790)
1. Critical Review on the Different Roles of Exosomes in TNBC and Exosomal-Mediated Delivery of microRNA/siRNA/lncRNA and Drug Targeting Signalling Pathways in Triple-Negative Breast Cancer.
Banerjee M; Rajeswari VD
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838790
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel-resistant triple-negative breast cancer cell-derived exosomal lncRNA LINC00667 reduces the chemosensitivity of breast cancer cells to docetaxel via targeting miR-200b-3p/Bcl-2 axis.
Li J; Kang J; Liu W; Liu J; Pan G; Mao A; Zhang Q; Lu J; Ding J; Li H
Eur J Histochem; 2022 Oct; 66(4):. PubMed ID: 36281649
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p.
Xing L; Tang X; Wu K; Huang X; Yi Y; Huan J
Aging (Albany NY); 2020 Dec; 13(1):424-436. PubMed ID: 33290256
[TBL] [Abstract][Full Text] [Related]
4. Exosomes deliver lncRNA DARS-AS1 siRNA to inhibit chronic unpredictable mild stress-induced TNBC metastasis.
Liu X; Zhang G; Yu T; He J; Liu J; Chai X; Zhao G; Yin D; Zhang C
Cancer Lett; 2022 Sep; 543():215781. PubMed ID: 35688263
[TBL] [Abstract][Full Text] [Related]
5. Exosomes in triple negative breast cancer: Garbage disposals or Trojan horses?
Goh CY; Wyse C; Ho M; O'Beirne E; Howard J; Lindsay S; Kelly P; Higgins M; McCann A
Cancer Lett; 2020 Mar; 473():90-97. PubMed ID: 31904485
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
Na-Er A; Xu YY; Liu YH; Gan YJ
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
[TBL] [Abstract][Full Text] [Related]
7. Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer.
Li T; Tao Z; Zhu Y; Liu X; Wang L; Du Y; Cao J; Wang B; Zhang J; Hu X
Cell Death Dis; 2021 Jul; 12(7):684. PubMed ID: 34238922
[TBL] [Abstract][Full Text] [Related]
8. LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other.
Liu AN; Qu HJ; Gong WJ; Xiang JY; Yang MM; Zhang W
J Cell Biochem; 2019 Sep; 120(9):14860-14866. PubMed ID: 31033015
[TBL] [Abstract][Full Text] [Related]
9. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.
Zhu Y; Tao Z; Chen Y; Lin S; Zhu M; Ji W; Liu X; Li T; Hu X
Breast Cancer Res Treat; 2022 May; 193(1):65-81. PubMed ID: 35254603
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
11. Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer.
Li S; Wu Y; Ding F; Yang J; Li J; Gao X; Zhang C; Feng J
Nanoscale; 2020 May; 12(19):10854-10862. PubMed ID: 32396590
[TBL] [Abstract][Full Text] [Related]
12. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
Mitobe Y; Ikeda K; Sato W; Kodama Y; Naito M; Gotoh N; Miyata K; Kataoka K; Sasaki H; Horie-Inoue K; Inoue S
Cancer Sci; 2020 Jul; 111(7):2440-2450. PubMed ID: 32437068
[TBL] [Abstract][Full Text] [Related]
13. The stromal loss of miR-4516 promotes the FOSL1-dependent proliferation and malignancy of triple negative breast cancer.
Kim JE; Kim BG; Jang Y; Kang S; Lee JH; Cho NH
Cancer Lett; 2020 Jan; 469():256-265. PubMed ID: 31672492
[TBL] [Abstract][Full Text] [Related]
14. Exosomes in triple negative breast cancer: From bench to bedside.
Tang W; Xia M; Liao Y; Fang Y; Wen G; Zhong J
Cancer Lett; 2022 Feb; 527():1-9. PubMed ID: 34902521
[TBL] [Abstract][Full Text] [Related]
15. Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial.
Stevic I; Müller V; Weber K; Fasching PA; Karn T; Marmé F; Schem C; Stickeler E; Denkert C; van Mackelenbergh M; Salat C; Schneeweiss A; Pantel K; Loibl S; Untch M; Schwarzenbach H
BMC Med; 2018 Oct; 16(1):179. PubMed ID: 30301470
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the influence of Human Umbilical Cord Mesenchymal Stem Cells-derived exosomes loaded with miR-3182 on metastatic performance of Triple Negative Breast Cancer cells.
Khazaei-Poul Y; Shojaei S; Koochaki A; Ghanbarian H; Mohammadi-Yeganeh S
Life Sci; 2021 Dec; 286():120015. PubMed ID: 34614416
[TBL] [Abstract][Full Text] [Related]
17. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Landscape of Exosomes Reveals the Functional Contributions of CD151 in Triple-Negative Breast Cancer.
Li S; Li X; Yang S; Pi H; Li Z; Yao P; Zhang Q; Wang Q; Shen P; Li X; Ji J
Mol Cell Proteomics; 2021; 20():100121. PubMed ID: 34265469
[TBL] [Abstract][Full Text] [Related]
19. Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy.
Vaidya AM; Sun Z; Ayat N; Schilb A; Liu X; Jiang H; Sun D; Scheidt J; Qian V; He S; Gilmore H; Schiemann WP; Lu ZR
Bioconjug Chem; 2019 Mar; 30(3):907-919. PubMed ID: 30739442
[TBL] [Abstract][Full Text] [Related]
20. Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy.
Gong C; Tian J; Wang Z; Gao Y; Wu X; Ding X; Qiang L; Li G; Han Z; Yuan Y; Gao S
J Nanobiotechnology; 2019 Sep; 17(1):93. PubMed ID: 31481080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]